A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Social Anxiety Disorder (SAD)

In brief

This is a double-blind study to evaluate the efficacy and safety of ENX-102 in participants with social anxiety disorder (SAD).

Key facts

Study ID

NCT07193563

Run by

Engrail Therapeutics INC

People needed

47

Starts

2025-09-05

Expected to finish

2026-03-19

Last updated by the study team

2026-04-08

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• IMA Clinical Research Phoenix — Phoenix, Arizona, United States
• University of California — La Jolla, California, United States
• Neuroresearch Group — Los Angeles, California, United States
• Excell Research, Inc. — Oceanside, California, United States
• Anderson Clinical Research — Redlands, California, United States
• California Neuroscience Research, LLC — Sherman Oaks, California, United States
• Sunwise Clincial Research — Walnut Creek, California, United States
• Mountain View Clinical Research — Denver, Colorado, United States
• CNS Health — Jacksonville, Florida, United States
• Clinical Neuroscience Solutions, Inc. — Orlando, Florida, United States
• CenExel iResearch, LLC — Savannah, Georgia, United States
• IMA Clinical Research — Las Vegas, Nevada, United States
• Redbird Research — Las Vegas, Nevada, United States
• Cenexel HRI — Berlin, New Jersey, United States
• SPRI Clinical Trials, LLC — Brooklyn, New York, United States
• Neurobehavioral Research, Inc. — Cedarhurst, New York, United States
• Clinical Neurosciences, Inc — Memphis, Tennessee, United States
• Austin Clinical Trials Partners — Austin, Texas, United States
• Grayline Research Center — Wichita Falls, Texas, United States
• Core Clinical Research — Everett, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.